Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young
- 31 July 2013
- journal article
- Published by Elsevier BV in Clinical Neurology and Neurosurgery
- Vol. 115 (7), 1088-1093
- https://doi.org/10.1016/j.clineuro.2012.11.003
Abstract
No abstract availableKeywords
Funding Information
- Shire, Belgium
This publication has 28 references indexed in Scilit:
- Response to Letter Regarding Belgian Fabry Study: Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular DiseaseStroke, 2011
- Mutations of the GLA Gene in Young Patients With StrokeStroke, 2010
- Frequency of Unrecognized Fabry Disease Among Young European-American and African-American Men With First Ischemic StrokeStroke, 2010
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic strokeClinical Neurology and Neurosurgery, 2007
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*American Journal of Human Genetics, 2006
- Significance of screening for Fabry disease among male dialysis patientsClinical and Experimental Nephrology, 2005
- Fabry disease: Characterization of ?-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency alleleHuman Mutation, 2003
- A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CTStroke, 2001
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959